Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Naminidil. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCC9 known ✓ | O60706 | 9/20 | 1.00 |
| ▸ | KCNJ11 known ✓ | Q14654 | 9/20 | 1.00 |
| ▸ | ABCC8 known ✓ | Q09428 | 1/20 | 0.38 |
| ▸ | KCNJ8 known ✓ | Q15842 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.71 |
| ▸ | LMNA | P02545 | 2/20 | 0.71 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.71 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.71 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.71 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.71 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.71 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.71 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.71 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.71 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.71 |
| ▸ | GLA | P06280 | 1/20 | 0.71 |
| ▸ | BLM | P54132 | 1/20 | 0.71 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.71 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.71 |
| ▸ | P2RX7 | Q99572 | 3/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Naminidil SCHEMBL1650535 | 1.00 | ABCC9 (1.00) | ABCC9KCNJ11CYP3A4LMNACYP1A2 | |
| SCHEMBL9298619 | 0.84 | KCNJ11 (0.72) | ABCC9KCNJ11CYP3A4LMNACYP1A2 | |
| SCHEMBL9298614 | 0.84 | KCNJ11 (0.72) | ABCC9KCNJ11CYP3A4LMNACYP1A2 | |
| Pinacidil Anhydrous SCHEMBL65787 | 0.83 | ABCC9 (1.00) | ABCC9KCNJ11CYP3A4LMNACYP1A2 | |
| Pinacidil Anhydrous SCHEMBL9351684 | 0.83 | ABCC9 (1.00) | ABCC9KCNJ11CYP3A4LMNACYP1A2 | |
| Pinacidil Anhydrous SCHEMBL9260276 | 0.83 | ABCC9 (1.00) | ABCC9KCNJ11CYP3A4LMNACYP1A2 | |
| Pinacidil Anhydrous SCHEMBL1650693 | 0.83 | ABCC9 (1.00) | ABCC9KCNJ11CYP3A4LMNACYP1A2 | |
| (R)-Pinacidil SCHEMBL29484626 | 0.83 | ABCC9 (1.00) | ABCC9KCNJ11CYP3A4LMNACYP1A2 | |
| SCHEMBL9298428 | 0.83 | KCNJ11 (0.70) | ABCC9KCNJ11CYP3A4LMNACYP1A2 | |
| SCHEMBL9298427 | 0.83 | KCNJ11 (0.70) | ABCC9KCNJ11CYP3A4LMNACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050009733-A1 | Compositions of a cyclooxygenase-2 selective inhibitor and a potassium ion channel modulator for the treatment of central nervous system damage | PHARMACIA CORPORATION | 2005-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050009733-A1 | Compositions of a cyclooxygenase-2 selective inhibitor and a potassium ion channel modulator for the treatment of central nervous system damage | KCNJ2, KCNN2, KCNK2 | ABCC9 633/4885KCNJ11 38/4885ABCC8 1479/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.